Repligen (Germany) Top Insiders

RGN Stock  EUR 141.40  1.35  0.95%   
Repligen employs about 2 K people. The company is managed by 10 executives with a total tenure of roughly 4725 years, averaging almost 472.0 years of service per executive, having 202.5 employees per reported executive. Examination of Repligen's management performance can provide insight into the company performance.
Christine Gebski  Insider
VP Chromatography
Kimberly Cornwell  Insider
Global Counsel
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For more detail on how to invest in Repligen Stock please use our How to Invest in Repligen guide.

Repligen Management Team Effectiveness

The company has return on total asset (ROA) of 0.0509 % which means that it generated a profit of $0.0509 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1016 %, meaning that it generated $0.1016 on every $100 dollars invested by stockholders. Repligen's management efficiency ratios could be used to measure how well Repligen manages its routine affairs as well as how well it operates its assets and liabilities.
Repligen owns a total of 55.56 Million outstanding shares. The majority of Repligen outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Repligen to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Repligen. Please pay attention to any change in the institutional holdings of Repligen as this could imply that something significant has changed or is about to change at the company. Also note that almost two million five hundred thirty-nine thousand two hundred eleven invesors are currently shorting Repligen expressing very little confidence in its future performance.
Some institutional investors establish a significant position in stocks such as Repligen in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Repligen, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Repligen Workforce Comparison

Repligen is currently regarded as top stock in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 20,727. Repligen holds roughly 2,025 in number of employees claiming about 10% of stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.23 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.25 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.25.

Repligen Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Repligen Price Series Summation is a cross summation of Repligen price series and its benchmark/peer.

Repligen Notable Stakeholders

A Repligen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Repligen often face trade-offs trying to please all of them. Repligen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Repligen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
String symbol = request.getParameter("s");

About Repligen Management Performance

The success or failure of an entity such as Repligen often depends on how effective the management is. Repligen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Repligen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Repligen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Repligen Corporation develops, manufactures, and sells products used to enhance the interconnected phases of the biological drug manufacturing process in North America, Europe, APAC, and internationally. The company was founded in 1981 and is headquartered in Waltham, Massachusetts. REPLIGEN CORP operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 548 people.

Repligen Workforce Analysis

Traditionally, organizations such as Repligen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Repligen within its industry.

Repligen Manpower Efficiency

Return on Repligen Manpower

Revenue Per Employee395.8K
Revenue Per Executive80.2M
Net Income Per Employee91.8K
Net Income Per Executive18.6M

Complementary Tools for Repligen Stock analysis

When running Repligen's price analysis, check to measure Repligen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repligen is operating at the current time. Most of Repligen's value examination focuses on studying past and present price action to predict the probability of Repligen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repligen's price. Additionally, you may evaluate how the addition of Repligen to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Valuation
Check real value of public entities based on technical and fundamental data